CJC-1295

€ 46.00

10mg

A long-acting growth hormone-releasing hormone (GHRH) analog studied for its ability to stimulate growth hormone release from the pituitary gland. This can subsequently influence HGH and IGF-1 levels.

Storage

  • This product can be used not more than 3 years from the production date (see box).
  • After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C – 8°C.
  • Store vials in an upright position.
  • Store in a refrigerator (2°C – 8°C). Keep in the outer carton in order to protect from light.
  • For one month can be stored at room temperature.

What is CJC-1295

CJC-1295 is a modified 30-amino-acid peptide that functions as a growth hormone-releasing hormone (GHRH) analog. It has been studied for its ability to influence growth hormone secretion. Nouveaux Estonia

  • Type: Synthetic GHRH analog
  • Structure: 30 amino acids with substitutions at positions 2, 8, 15, and 27
  • Research focus: Growth hormone and related IGF-1 signaling
  • Form: White, lyophilized powder
  • Research use: Intended for laboratory research. The injection and reconstitution details in the original description should not be treated as instructions for human administration.

Mechanism of Action

CJC-1295 is a modified growth hormone-releasing hormone (GHRH) analog that has been investigated for its effects on the GH/IGF-1 signaling pathway.

  • GH stimulation: CJC-1295 is designed to interact with GHRH-related pathways and influence growth hormone release from the pituitary gland.
  • IGF-1 pathway: Changes in GH secretion can subsequently affect circulating IGF-1 levels.
  • Research areas: Studies have examined CJC-1295 in relation to body composition, muscle mass, physical performance, sleep, and metabolic processes.
  • Sleep research: Growth hormone signaling has been investigated in connection with sleep architecture, including slow-wave sleep.
  • Human evidence: Clinical research has demonstrated changes in GH and IGF-1 following CJC-1295 exposure, but claims of guaranteed muscle gain, fat loss, improved athletic performance, or anti-aging effects are not established medical outcomes.
  • Half-life: Pharmacokinetic properties depend on the specific CJC-1295 formulation, so the commonly quoted 10–30 minute half-life should not be applied universally.
  • Research status: CJC-1295 remains an investigational peptide, and its long-term safety and effectiveness for performance enhancement, weight loss, or anti-aging have not been established.

The original claims about specific percentages of muscle gain, abdominal-fat reduction, athletic improvement, and guaranteed. Results should therefore be avoided unless they can be directly supported by the underlying clinical studies.

Dosage

Recommended dosage of CJC-1295: 100mcg (0.10mg) once per day for anti-aging.

Between 200-300 mcg, divided in two or three doses per day for muscle gain and fat loss, directed via subcutaneous injections.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295”

Your email address will not be published. Required fields are marked *